Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival

doi:10.3748/wjg.v21.i21.6621

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 21

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7701)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

434

WORD

296

HTML

3043

Figures (1-3)

212

Tables (1-2)

190

Sum=4175

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1277

Download

2249

Sum=3526

Jun 7, 2015 (publication date) through Nov 19, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jun 7, 2015; 21(21): 6621-6630
Published online Jun 7, 2015. doi: 10.3748/wjg.v21.i21.6621

Full Size Figure Download Figure

Figure 1 Representative images of chronic pancreatitis and pancreatic ductal adenocarcinoma tissues immunostained for RASSF6. Representative micrographs of RASSF6 in pancreatic ductal adenocarcinoma (PDAC) cancerous tissues or chronic pancreatitis tissues by immunohistochemistry. A: Diffused cytoplasmic RASSF6 staining in chronic pancreatitis tissues; B: Representative negative staining of RASSF6 in PDAC; C: Extremely strong RASSF6 staining in pancreas islet (black arrow); D-F: Strongly positive RASSF6 staining in PDAC; G-I: Weakly positive RASSF6 staining in PDAC. Magnifications × 100 for A, B, D, E, G and H; × 200 for C, F and I.

Citation: Ye HL, Li DD, Lin Q, Zhou Y, Zhou QB, Zeng B, Fu ZQ, Gao WC, Liu YM, Chen RW, Li ZH, Chen RF. Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival. World J Gastroenterol 2015; 21(21): 6621-6630
URL: https://www.wjgnet.com/1007-9327/full/v21/i21/6621.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i21.6621